Deep Brain Stimulation Devices Market Size By Product Type (Single-Channel Deep Brain Stimulator, Dual-Channel Deep Brain Stimulator), By Application (Parkinson’s Disease, Essential Tremor), By End-User (Hospitals, Neurological Clinics), By Geographic Scope And Forecast

Global Deep Brain Stimulation Devices Market Size And Forecast

Deep Brain Stimulation Devices Market size was valued at USD 1.46 Billion in 2024 and is projected to reach USD 2.77 Billion by 2031, growing at a CAGR of 9.20% from 2024 to 2031.

• Deep brain stimulation (DBS) is a surgical procedure that involves implanting a medical device called a neurostimulator in the brain. The neurostimulator delivers electrical impulses to specific areas of the brain, which can help to improve symptoms of a variety of neurological disorders, including Parkinson’s disease, essential tremor, dystonia, and obsessive-compulsive disorder (OCD).
• The DBS device is programmable, allowing doctors to adjust the stimulation parameters, such as the amplitude, frequency, and pulse width, to optimize the therapeutic effect for each patient.

Global Deep Brain Stimulation Devices Market Dynamics

The key market dynamics that are shaping the Deep Brain Stimulation Devices market include

Key Market Drivers

• Rising Prevalence of Neurological DisordersConditions like Parkinson’s disease, essential tremor, and dystonia are becoming more common due to an aging population, improved diagnostics, and greater awareness. DBS offers a potential treatment option for these patients, providing relief from debilitating symptoms.
• Growing Geriatric PopulationAs people live longer, the likelihood of developing age-related neurological disorders, such as Parkinson’s disease, essential tremor, and Lewy body dementia, increases. DBS can be a valuable tool for managing these conditions in elderly patients. DBS therapy is effective in improving motor function, reducing tremors and rigidity, and alleviating other symptoms that can significantly impair the quality of life for elderly patients. Additionally, DBS is often a more favorable option for elderly patients compared to traditional brain surgery due to its minimally invasive nature and shorter recovery time. This makes DBS a potentially life-changing treatment for a growing population of elderly individuals struggling with neurological disorders.
• Minimally Invasive SurgeryDBS surgery is less invasive compared to traditional brain surgery. This translates to faster recovery times, less risk of complications, and a more favorable option for patients who may not be ideal candidates for major surgery.
• Technological AdvancementsDBS devices are becoming more effective and user-friendly with features like directional leads, programmable settings, and (in development) closed-loop systems that can adjust stimulation automatically.

Key Challenges

• Need for Long-Term DataDBS is a relatively new treatment option, and long-term data on its safety and efficacy is still being collected. This lack of long-term data can make some healthcare providers and patients cautious about adopting DBS.
• Limited Availability DBS surgery is complex and requires highly trained neurosurgeons and a team with DBS expertise. Additionally, specialized facilities with advanced imaging equipment and DBS-equipped operating rooms are necessary. This limited availability of resources restricts access to DBS for some patients, particularly in rural or remote areas.
• High Cost DBS surgery is expensive, encompassing the device itself, surgery, hospital stay, programming sessions, follow-up care, and potential ongoing battery replacements. This can be a major barrier for patients, especially without adequate insurance coverage.

Key Trends

• Rise of Closed-Loop SystemsThese next-generation DBS systems are under development and aim to automatically adjust stimulation parameters based on a patient’s real-time brain activity. This could optimize therapy and potentially reduce the burden on patients and doctors. Closed-loop DBS holds immense promise for the future of the market.
• Focus on Minimally Invasive Techniques Minimally invasive surgical techniques for DBS implantation are being developed and refined. This reduces recovery times, minimizes complications, and makes DBS a more attractive option for patients.

Global Deep Brain Stimulation Devices Market Dynamics

Here is a more detailed regional analysis of the Deep Brain Stimulation Devices market

North America

• According to analysts, North America is estimated to dominate the Deep Brain Stimulator market during the forecast period. North America has a high prevalence of neurological disorders that are prime targets for DBS therapy, such as Parkinson’s disease, essential tremor, and dystonia. DBS has emerged as a promising treatment option for these conditions, offering significant improvement in motor function and quality of life for patients who experience limitations despite medication or who cannot tolerate medications well.
• North America boasts a well-developed healthcare infrastructure with access to cutting-edge medical facilities and skilled neurosurgeons experienced in DBS surgery. This facilitates the adoption of new technologies like DBS and ensures patients have access to qualified specialists.
• The high demand for DBS in North America creates a strong incentive for manufacturers to invest in research and development. This fosters advancements in DBS technology, leading to more precise, effective, and user-friendly devices. These advancements further fuel market growth by making DBS a more attractive option for both patients and healthcare providers.

Asia Pacific

• The Asia Pacific region is experiencing an increase in neurological disorders like Parkinson’s disease, essential tremor, and dystonia. This rise is attributed to factors like an aging population, improved diagnostics, and greater public awareness of these conditions. DBS offers a promising treatment option for these patients, driving up demand for the technology.
• Economic growth in many Asian countries is leading to rising disposable incomes. This translates to a larger population with the financial means to afford expensive treatments like DBS surgery. Furthermore, as disposable incomes rise, patients are likely to become more willing to spend on healthcare, particularly for treatments that can significantly improve their quality of life. This trend is expected to create a more robust market for DBS devices in the Asia Pacific region.
• Governments and private investors are increasingly allocating resources towards healthcare infrastructure development in the Asia Pacific region. This includes building new hospitals and medical facilities equipped with advanced technologies like DBS. Additionally, there’s a growing focus on training neurosurgeons and other specialists skilled in DBS procedures. This expanding infrastructure will enhance access to DBS therapy for patients in the region.

Europe

• Europe has a large and aging population, which is a significant factor driving the growth of the Deep Brain Stimulation (DBS) devices market in the region. This aging population is more susceptible to developing neurodegenerative disorders like Parkinson’s disease, essential tremor, and dystonia, all of which can be effectively treated with DBS therapy.
• Many European countries boast well-developed healthcare systems with a network of hospitals and specialized clinics equipped with advanced medical technology. This includes access to high-resolution imaging equipment for pre-surgical planning and DBS lead placement, as well as specialized operating rooms suited for DBS surgery. Additionally, a growing number of European healthcare facilities have teams of skilled neurosurgeons experienced in DBS procedures. This ensures that patients in Europe have access to qualified specialists who can perform DBS surgery safely and effectively.
• Increased public and medical awareness of DBS as a treatment option for neurological disorders is leading to more patients and doctors in Europe considering it. Media coverage of DBS success stories. News articles, documentaries, and patient testimonials can raise public awareness of DBS and its ability to improve the quality of life for people with neurological disorders.

Global Deep Brain Stimulation Devices Market Segmentation Analysis

The Global Deep Brain Stimulation Devices Market is Segmented based on Product Type, Application, End-User, and Geography.

Deep Brain Stimulation Devices Market, By Product Type

• Single-channel Deep Brain Stimulator
• Dual-channel Deep Brain Stimulator

Based on Product Type, the market is bifurcated into Single-channel Deep Brain Stimulator and Dual-channel Deep Brain Stimulator. Because of its increased acceptance in surgical operations, the dual-channel category dominated the deep brain stimulation device market, accounting for 57.2% of revenue in 2020. Dual channel devices are among the safest and most effective in surgical operations. As a result, the segment is being driven by the high frequency of disabling neurological disorders, an increasing number of surgical operations for Parkinson’s disease, and an expanding number of hospitals that use dual-channel DBS devices.

Deep Brain Stimulation Devices Market, By Application

• Parkinson’s Disease
• Essential Tremor
• Dystonia
• Epilepsy
• Others

Based on Application, the market is bifurcated into Parkinson’s Disease, Essential Tremor, Dystonia, Epilepsy, and Others. The Parkinson’s disease segment dominated the market for deep brain stimulation devices and accounted for a revenue share of 65.2% in 2020 owing to the increasing number of U.S. FDA approvals for deep brain stimulation therapies and the high prevalence of PD worldwide. In December 2017, Boston Scientific Corporation received approval for the Vercise deep brain stimulation device system from the U.S. FDA for the treatment of PD. According to the Parkinson’s Foundation, around 60,000 people in the U.S. are diagnosed with PD every year. This is expected to drive the segment growth in the coming years.

Deep Brain Stimulation Devices Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Neurological Clinics
• Others

Based on End-User, the market is further segmented into Hospitals, Ambulatory Surgical Centers, Neurological Clinics, and Others. The hospital segment held the largest market share for deep brain stimulation devices. Furthermore, due to an increase in the number of hospitals around the world, the category is predicted to develop at the quickest rate during the projection period. Neurological problems are also diagnosed and treated using advanced equipment by a trained neurologist, who can be found in specialist hospitals. As a result, the hospital segment of the Global Deep Brain Stimulation Devices Market is experiencing a boom in growth.

Deep Brain Stimulation Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the Global Deep Brain Stimulation Devices Market. is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America dominated the Deep Brain Stimulation Devices Market with a share of 51.9% in 2020 owing to an increase in FDA approvals for deep brain stimulation devices in clinical applications. For instance, in 2015, the U.S. FDA approved a deep brain stimulation device, Brio, for the treatment of Parkinson’s disease. Furthermore, an increasing number of patients diagnosed with PD coupled with rising government funding and initiatives for raising awareness about movement disorders is expected to drive the demand for deep brain stimulation devices in the region.

Key Players

The “Global Deep Brain Stimulation Devices Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, LivaNova PLC, Aleva NeuroTechnologies, Beijing PINS Medical Co., Ltd, SceneRay Co Ltd., and Michigan Tech Researchers.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Deep Brain Stimulator Market Recent Developments

• In June 2020, Percept, a deep brain stimulation device from Medtronic, was approved by the FDA. BrainSense technology is used by the company to continuously capture, record, and monitor brain signals in individuals with neurological diseases. It has the potential to aid clinicians in tracking patient brain activity and enhancing data-driven, tailored neurostimulation treatment.
• In 2021, Abbott, received FDA approval for its new rechargeable deep brain stimulation system, the Liberta RC, which is noted for being the smallest and having the longest battery life among DBS devices. This innovation aims to enhance patient comfort and convenience by reducing the frequency of recharges​.
• In 2020, Medtronic received FDA approval for their new DBS lead, designed for better targeting of brain regions & has made significant advancements with its Percept™ RC neurostimulator, which features BrainSense technology. This system, approved by the FDA, allows for continuous brain activity recording and adaptive stimulation, providing more personalized therapy for patients​
• In 2021, Boston Scientific launched the Vercise Genus™ DBS system, their fourth-generation technology, which includes Bluetooth-enabled, rechargeable, and non-rechargeable implantable pulse generators. This system is designed for conditional use in MRI environments and aims to provide targeted and adjustable therapy options for Parkinson’s disease and other movement disorders

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any